Fisher & Paykel Healthcare

The airways of neonates and infants are fundamentally different from those of adults in terms of anatomy and physiology. The delivery of respiratory gases to these populations requires special considerations for several reasons: To ensure maintained function of the mucociliary transport system, which plays a crucial role in airway defense; to aid in thermoregulation; and to ensure effective ventilation is provided to these inherently vulnerable patients. Our products, designed across the care continuum with these considerations in mind, deliver heated, humidified support for these populations. Find out more about the infant respiratory care continuum here: https://bit.ly/3XWmeYv

Ready to start your career and make an impact in one of NZ’s largest internship programmes? We have internship positions open across many of our business areas. Check them out and apply now https://bit.ly/463oTS6 Applications close 31 July 2024.

Control oxygen from the device. High-pressure oxygen input allows precise FiO2 adjustment directly on the device. A dual-input manifold ensures a smooth transition to portable oxygen for patient transfer or ambulation. Visit our webpage to discover all the features that make the Airvo 3 the next generation in mobile respiratory support. https://bit.ly/4cezxYl #makeyourflowmatter F&P, Optiflow, and Airvo are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see http://fphcare.com/ip.

Care to launch your career? Join us as an intern this summer! ✔️ Paid internship from November to February ✔️ Hands-on experience ✔️ Learn from world-leading experts ✔️ Make a difference to millions of patients worldwide Find out more about life at F&P Healthcare and apply at: https://bit.ly/4bNCM8o

📢 The countdown is on! We’re looking for university students who care to make a difference. Summer internship applications open next Monday 15 July, so stay tuned! #FPHcareers #internsthatcare #interns #internroles #caretomakeadifference

Quick selection and adjustment of settings. A decade of experience is has informed the development of the menu system. A focus of the Airvo 3 has been on usability, the creation of an intuitive and easy-to-use device that allows quick selection and adjustment of therapy settings. Visit our webpage to discover all the features that make the Airvo 3 the next generation in mobile respiratory support. https://bit.ly/3L05YxY #makeyourflowmatter F&P, Optiflow, and Airvo are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see http://fphcare.com/ip.

Last week we welcomed five marketing students from Auckland University of Technology for an opportunity to shadow our early career marketers. This experience was our unique adaptation of AUT’s Shadow a Leader Program. During their time here, the students got a first-hand look at the possibilities of a career in B2B Marketing from a leading global medical device company and particularly enjoyed a tour of our world-class manufacturing. One of the students said: "I feel inspired and eager to explore more." The future of marketing is bright! 

The Airvo 3 is designed to get your patients moving. An integrated battery gives you 40 minutes* to move your patient from the ER to the ICU, from the ICU to X-ray, from bronchoscopy back to the ward, or to get your patient out of bed and started on the road to recovery. Visit our webpage to discover all the features that make the Airvo 3 the next generation in mobile respiratory support. https://bit.ly/3VC6uH5 #makeyourflowmatter *typical running time F&P, Optiflow, and Airvo are trademarks of Fisher & Paykel Healthcare Limited. For patent information, see http://fphcare.com/ip.

The power of commitment, collaboration and creative problem-solving made our winners stand out at the FY24 Global Continuous Improvement Awards held in Auckland last week. The event, themed ‘Impact’, showcased how continuous improvement (CI) has made a real impact to our business, our customers, and ultimately, the patients who use our products and therapies.   From a record number of submissions, the judges selected 34 finalists with Area Awards presented to the winners across six business areas. A cross-functional New Zealand-based project, that significantly reduced time and resources for an essential business process, won the supreme Overall Global CI Award. Presenting the winners with the CI Möbius trophy, CEO Lewis Gradon said, “When I see these continuous improvement projects making such a positive impact, it gives me confidence in the future of our business. At F&P, we know that CI never stops. It's a journey and I'm keen to see CI embedded everywhere, in every team, demonstrating results and contributing to our growth.”   VP - Human Resources Nicola Talbot said, “It's inspiring to see our nominees and winners bringing their ideas to life and making a difference to the way we work. Thank you very much for your contributions and congratulations to everyone!”   #continuousimprovement #impact #committment #collaboration

Fisher & Paykel Healthcare interfaces are meticulously designed and engineered to deliver intended therapies to the vulnerable neonatal population. Our dedicated team is continuously innovating to help clinicians improve care and outcomes for their patients. To learn why the design of a neonatal interface can affect the desired therapy results, head to: https://lnkd.in/eMM7dceN #neonatology #nicu #cpap #nhf #rds